Get Premium to unlock powerful stock data

Bvf Inc Buys Galapagos NV, Amarin Corp PLC, Aadi Bioscience Inc, Sells Merus NV, argenx SE, Relay Therapeutics Inc

Author's Avatar
insider
Nov 17, 2021
Article's Main Image
Investment company Bvf Inc (Current Portfolio) buys Galapagos NV, Amarin Corp PLC, Aadi Bioscience Inc, Kymera Therapeutics Inc, Tyra Biosciences Inc, sells Merus NV, argenx SE, Relay Therapeutics Inc, Therapeutics Acquisition Corp, Forte Biosciences Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Bvf Inc. As of 2021Q3, Bvf Inc owns 75 stocks with a total value of $2.6 billion. These are the details of the buys and sells.

For the details of BVF INC's stock buys and sells, go to https://www.gurufocus.com/guru/bvf+inc/current-portfolio/portfolio

These are the top 5 holdings of BVF INC
  1. GH Research PLC (GHRS) - 9,275,158 shares, 7.98% of the total portfolio.
  2. Kymera Therapeutics Inc (KYMR) - 3,180,658 shares, 7.29% of the total portfolio. Shares added by 20.91%
  3. Olema Pharmaceuticals inc (OLMA) - 6,661,503 shares, 7.16% of the total portfolio.
  4. Arcus Biosciences Inc (RCUS) - 3,229,822 shares, 4.39% of the total portfolio. Shares added by 15.44%
  5. Merus NV (MRUS) - 5,060,071 shares, 4.34% of the total portfolio.
New Purchase: Galapagos NV (GLPG)

Bvf Inc initiated holding in Galapagos NV. The purchase prices were between $52.17 and $70.2, with an estimated average price of $59.52. The stock is now traded at around $52.300000. The impact to a portfolio due to this purchase was 2.3%. The holding were 1,119,733 shares as of 2021-09-30.

New Purchase: Aadi Bioscience Inc (AADI)

Bvf Inc initiated holding in Aadi Bioscience Inc. The purchase prices were between $0 and $32.66, with an estimated average price of $27.53. The stock is now traded at around $25.360000. The impact to a portfolio due to this purchase was 1.31%. The holding were 1,147,052 shares as of 2021-09-30.

New Purchase: Tyra Biosciences Inc (TYRA)

Bvf Inc initiated holding in Tyra Biosciences Inc. The purchase prices were between $16.91 and $26, with an estimated average price of $19.11. The stock is now traded at around $27.600000. The impact to a portfolio due to this purchase was 1.16%. The holding were 1,694,933 shares as of 2021-09-30.

New Purchase: POINT Biopharma Global Inc (PNT)

Bvf Inc initiated holding in POINT Biopharma Global Inc. The purchase prices were between $7.42 and $11.26, with an estimated average price of $9.13. The stock is now traded at around $9.030000. The impact to a portfolio due to this purchase was 0.83%. The holding were 2,772,226 shares as of 2021-09-30.

New Purchase: Alpine Immune Sciences Inc (ALPN)

Bvf Inc initiated holding in Alpine Immune Sciences Inc. The purchase prices were between $8.19 and $11.31, with an estimated average price of $9.21. The stock is now traded at around $13.750000. The impact to a portfolio due to this purchase was 0.66%. The holding were 1,589,495 shares as of 2021-09-30.

New Purchase: Elevation Oncology Inc (ELEV)

Bvf Inc initiated holding in Elevation Oncology Inc. The purchase prices were between $7.66 and $16.11, with an estimated average price of $10.88. The stock is now traded at around $7.910000. The impact to a portfolio due to this purchase was 0.48%. The holding were 1,590,298 shares as of 2021-09-30.

Added: Amarin Corp PLC (AMRN)

Bvf Inc added to a holding in Amarin Corp PLC by 564.76%. The purchase prices were between $3.94 and $5.84, with an estimated average price of $4.91. The stock is now traded at around $4.110000. The impact to a portfolio due to this purchase was 1.93%. The holding were 11,407,182 shares as of 2021-09-30.

Added: Kymera Therapeutics Inc (KYMR)

Bvf Inc added to a holding in Kymera Therapeutics Inc by 20.91%. The purchase prices were between $47.8 and $66.66, with an estimated average price of $57.98. The stock is now traded at around $61.170000. The impact to a portfolio due to this purchase was 1.26%. The holding were 3,180,658 shares as of 2021-09-30.

Added: Lexicon Pharmaceuticals Inc (LXRX)

Bvf Inc added to a holding in Lexicon Pharmaceuticals Inc by 71.07%. The purchase prices were between $3.38 and $5.35, with an estimated average price of $4.12. The stock is now traded at around $5.090000. The impact to a portfolio due to this purchase was 1.12%. The holding were 14,360,000 shares as of 2021-09-30.

Added: Crinetics Pharmaceuticals Inc (CRNX)

Bvf Inc added to a holding in Crinetics Pharmaceuticals Inc by 3828.66%. The purchase prices were between $16.88 and $25.23, with an estimated average price of $20.96. The stock is now traded at around $27.580000. The impact to a portfolio due to this purchase was 0.76%. The holding were 953,879 shares as of 2021-09-30.

Added: Rain Therapeutics Inc (RAIN)

Bvf Inc added to a holding in Rain Therapeutics Inc by 52.00%. The purchase prices were between $13.21 and $20.91, with an estimated average price of $17.05. The stock is now traded at around $16.850000. The impact to a portfolio due to this purchase was 0.59%. The holding were 2,957,807 shares as of 2021-09-30.

Added: Verastem Inc (VSTM)

Bvf Inc added to a holding in Verastem Inc by 32.70%. The purchase prices were between $2.54 and $4.07, with an estimated average price of $3.07. The stock is now traded at around $3.200000. The impact to a portfolio due to this purchase was 0.44%. The holding were 14,977,258 shares as of 2021-09-30.

Sold Out: Merus NV (MRUS)

Bvf Inc sold out a holding in Merus NV. The sale prices were between $16.48 and $27.23, with an estimated average price of $21.52.

Sold Out: Therapeutics Acquisition Corp (RACA)

Bvf Inc sold out a holding in Therapeutics Acquisition Corp. The sale prices were between $10.27 and $10.27, with an estimated average price of $10.27.

Sold Out: Forte Biosciences Inc (FBRX)

Bvf Inc sold out a holding in Forte Biosciences Inc. The sale prices were between $2.96 and $36.67, with an estimated average price of $22.1.

Sold Out: Immunovant Inc (IMVT)

Bvf Inc sold out a holding in Immunovant Inc. The sale prices were between $7.01 and $11.37, with an estimated average price of $9.05.

Sold Out: Centessa Pharmaceuticals PLC (CNTA)

Bvf Inc sold out a holding in Centessa Pharmaceuticals PLC. The sale prices were between $16.7 and $23.11, with an estimated average price of $20.76.



Here is the complete portfolio of BVF INC. Also check out:

1. BVF INC's Undervalued Stocks
2. BVF INC's Top Growth Companies, and
3. BVF INC's High Yield stocks
4. Stocks that BVF INC keeps buying
Rating:
NaN / 5 ( votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles

Q&A with Gurus